Author

A. Martinson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

F. Moussavi-Harami· 2 shared G. Flint· 2 shared J. Davis· 2 shared K. B. Kooiker· 2 shared M. Regnier· 2 shared T. S. McMillen· 2 shared A. J. Goldstein· 1 shared A.-Y. Tu· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

F. Moussavi-Harami

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Danicamtiv increases myosin recruitment and alters the chemomechanical cross bridge cycle in cardiac muscle

K. B. Kooiker, S. Mohran, K. L. Turner, W. Ma, G. Flint, L. Qi, C. Gao, Y. Zheng, T. S. McMillen, C. Mandrycky, A. Martinson, M. Mahoney-Schaefer, J. C. Freeman, E. G. Costales Arenas, A.-Y. Tu, , F. Moussavi-Harami

This study investigates how Danicamtiv increases force and alters cardiac muscle contraction kinetics by modulating myosin function and cross bridge dynamics in cardiac tissue.

bioRxiv · Jan 31, 2023 · PreprintPhysiology

Correcting dilated cardiomyopathy with fibroblast-targeted p38 deficiency

R. C. Bretherton, I. M. Reichardt, K. A. Zabrecky, A. J. Goldstein, L. R. J. Bailey, D. Bugg, T. S. McMillen, K. B. Kooiker, G. Flint, A. Martinson, J. Gunaje, F. Koser, W. A. Linke, M. Regnier, F. Moussavi-Harami, , J. Davis

This study shows that targeting p38 in cardiac fibroblasts can reverse fibrosis and improve cardiomyocyte function in a mouse model of dilated cardiomyopathy.

bioRxiv · Jan 23, 2023 · PreprintCell Biology